6 results match your criteria: "Jiangyou Second People's Hospital[Affiliation]"
World J Cardiol
September 2024
Department of Cardiology, Jiangyou Second People's Hospital, Jiangyou 621701, Sichuan Province, China.
World J Clin Cases
March 2024
Department of Cardiology, The General Hospital of Western Theater Command, Chengdu 610083, Sichuan Province, China.
Medicine (Baltimore)
August 2023
Department of Gastroenterology, Clinical Medical College and The First Affiliated Hospital of Chengdu Medical College, Chengdu, China.
The management of cirrhotic patient with encephalopathy and acute variceal bleeding (AVB) remains a clinical challenge with a high mortality. Early endoscopic therapies are frequently applied in patients with AVB. However, the application of general anesthesia in endoscopic surgery for patients with hepatic encephalopathy (HE) is pretty challenging.
View Article and Find Full Text PDFOncologist
December 2020
Department of Oncology, Mianyang Central Hospital, Mianyang, People's Republic of China.
Lessons Learned: The efficacy of single-agent chemotherapy was not significantly different from that of double-agent chemotherapy in concurrent chemoradiotherapy for inoperable esophageal squamous cell carcinoma. Single-agent concurrent chemoradiotherapy had lower gastrointestinal and hematologic toxicity. Overall survival and progression-free survival were not significantly different between single- and double-agent concurrent chemoradiotherapy.
View Article and Find Full Text PDFPain Res Manag
April 2020
Chengdu University of Traditional Chinese Medicine, Sichuan, Chengdu 610075, China.
Background: Moxibustion has a therapeutic effect of reducing swelling and relieving pain in patients with rheumatoid arthritis (RA) but its mechanism is uncertain.
Objective: To evaluate the effect of moxibustion on serum levels of hypoxia-inducible factor-1 (HIF-1) and vascular endothelial growth factor (VEGF) in patients with RA and to explore the possible mechanism of moxibustion.
Methods: This study involved 46 RA patients who had fulfilled the inclusion criteria and were randomly assigned to a treatment group and a control group in an equal ratio.
Medicine (Baltimore)
December 2017
Department of Oncology, Mianyang Central Hospital, Mian Yang Department of Oncology, Affiliated Hospital of North Sichuan Medical College, Nan Chong Department of Oncology, Zigong Fourth People's Hospital, Zi Gong Department of Oncology, Ziyang People's Hospital, Zi Yang Department of Oncology, Guangyuan First People's Hospital, Guang Yuan Department of Oncology, Jiangyou People's Hospital Department of Oncology, Jiangyou Second People's Hospital, Jiang You Department of Oncology, Jianyang People's Hospital, Jian Yang, Sichuan, People's Republic of China.
Introduction: Chemotherapy regimens are often a 2-drug regimen in concurrent chemotherapy and radiotherapy for esophageal cancer (EC). However, some retrospective studies have suggested that for patients with EC receiving radiotherapy combined with 2-drug chemotherapy have the severe toxicity. And S-1 alone with the combination of radiotherapy treatment effect is good, and achieved good clinical remission rate.
View Article and Find Full Text PDF